The Role of the Placenta in Serotonin Production During Fetal Development
Author Information
Author(s): Bondarenko Nadezhda, Lifantseva Nadezhda, Voronova Svetlana, Melnikova Victoria, Vaiman Daniel
Primary Institution: Koltzov Institute of Developmental Biology of the Russian Academy of Sciences
Hypothesis
Can inflammation-induced changes in placental serotonin levels be prevented by immunoglobulin administration?
Conclusion
The placenta is the main source of serotonin during most prenatal development, and its modulation by inflammation can be prevented by immunoglobulin treatment.
Supporting Evidence
- The placenta is the leading source of serotonin during most stages of fetal development.
- Immunoglobulin administration can prevent the negative effects of inflammation on placental serotonin levels.
- Different stages of development show varying susceptibility to inflammation-induced changes in serotonin levels.
Takeaway
The placenta helps make serotonin for the baby, and if there is inflammation, giving immunoglobulins can help keep serotonin levels normal.
Methodology
The study involved immunohistochemistry to examine serotonin synthesis and HPLC to measure serotonin levels in placentas and fetal tissues at various developmental stages.
Potential Biases
Potential biases may arise from the use of animal models and the specific conditions under which the experiments were conducted.
Limitations
The study primarily focused on rat models, which may not fully represent human physiology.
Participant Demographics
Wistar rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website